Neuromuscular Disorders
Conference Coverage
Thromboembolic events more likely among CIDP patients with CVAD
AUSTIN, TEX. – Although the study matched patients by demographic factors, researchers did not adjust the analysis for risk factors or confounders...
Conference Coverage
CMT1A neuropathy improves with investigational drug PXT3003
AUSTIN, TEX. – Adverse events during treatment were similar across intervention and placebo groups, with similar rates of trial attrition.
Conference Coverage
Edasalonexent may slow progression of Duchenne muscular dystrophy
CHARLOTTE, N.C. – Functional measures and disease biomarkers stabilized when patients received the investigational NF-kB inhibitor.
Conference Coverage
Next-generation sequencing can shed light on neuropathy etiology
AUSTIN, TEX. – Researchers also found 81 variants of unknown significance in patients, and suggested some could be...
Conference Coverage
Primary periodic paralysis attacks reduced with long-term dichlorphenamide
AUSTIN, TEX. – The majority of paresthesia and cognition-related adverse events were mild or moderate with few participants discontinuing the...
Conference Coverage
Patients with Charcot-Marie-Tooth disease describe wide range of care
AUSTIN – An interim analysis examines the use of physical therapy, surgery, medications, orthoses, and walking aids in more than 400 adults with...
Conference Coverage
Researchers identify common reasons for misdiagnosis of ALS
AUSTIN – Particular clinical presentations and cognitive biases are associated with misdiagnosis of patients who...
Conference Coverage
Which patients are most likely to have a positive RNS test for myasthenia gravis?
AUSTIN, TEX. – The diagnostic yield of the test may be highest in patients with MGFA Class III or higher who are...
Conference Coverage
Study examines utility of repeat outpatient electrodiagnostic testing
AUSTIN, TEX. – Repeat testing for the same indication may not change symptom or disease management in about one-third of cases, a preliminary...
Conference Coverage
Neurologists consider flu shot safe in most patients with autoimmune neuromuscular disorders
AUSTIN, TEX. – Neurologists are circumspect about recommending influenza vaccination for patients with a history of...
Conference Coverage
Placebo response in negative rituximab BeatMG trial provides important lessons
AUSTIN, TEX. – The BeatMG trial offers clues and reinforces the need for placebo-controlled studies, Dr. Richard Nowak said.